Determine the necessary mass, volume, or concentration for preparing a solution.
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Used in biotechnology applications to inhibit protein synthesis. Used as a selection agent for cells transformed with kanamycin B (neoR, kanR) resistance gene.
Taxonomy Tree
| Kingdom | Organic compounds |
|---|---|
| Superclass | Organic oxygen compounds |
| Klasse | Organooxygen compounds |
| Subclass | Carbohydrates and carbohydrate conjugates |
| Intermediate Tree Nodes | Aminosaccharides - Aminoglycosides - Aminocyclitol glycosides - 2-deoxystreptamine aminoglycosides |
| Direct Parent | 4,6-disubstituted 2-deoxystreptamines |
| Alternative Parents | O-glycosyl compounds Aminocyclitols and derivatives Cyclohexanols Cyclohexylamines Organic sulfuric acids Monosaccharides Oxanes 1,2-aminoalcohols Polyols Acetals Oxacyclic compounds Organopnictogen compounds Organic oxides Monoalkylamines Hydrocarbon derivatives Primary alcohols |
| Molecular Framework | Aliphatic heteromonocyclic compounds |
| Substituents | 4,6-disubstituted 2-deoxystreptamine - Glycosyl compound - O-glycosyl compound - Aminocyclitol or derivatives - Cyclohexanol - Cyclohexylamine - Sulfuric acid - Cyclitol or derivatives - Monosaccharide - Oxane - Cyclic alcohol - Organic sulfuric acid or derivatives - 1,2-aminoalcohol - Secondary alcohol - Polyol - Acetal - Organoheterocyclic compound - Oxacycle - Organonitrogen compound - Primary aliphatic amine - Hydrocarbon derivative - Organic oxide - Primary amine - Organopnictogen compound - Organic nitrogen compound - Amine - Alcohol - Primary alcohol - Aliphatic heteromonocyclic compound |
| Beschreibung | This compound belongs to the class of organic compounds known as 4,6-disubstituted 2-deoxystreptamines. These are 2-deoxystreptamine aminoglycosides that a glycosidically linked to a pyranose of furanose unit at the C4- and C6-positions. |
| External Descriptors | aminoglycoside sulfate salt |
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Datum | Artikel |
|---|---|---|---|
| Certificate of Analysis | Apr 17, 2026 | K103025 | |
| Certificate of Analysis | Apr 17, 2026 | K103025 | |
| Certificate of Analysis | Apr 17, 2026 | K103025 | |
| Certificate of Analysis | Apr 17, 2026 | K103025 | |
| Certificate of Analysis | Jun 09, 2025 | K103025 | |
| Certificate of Analysis | Jun 09, 2025 | K103025 | |
| Certificate of Analysis | May 10, 2024 | K103025 | |
| Certificate of Analysis | May 10, 2024 | K103025 | |
| Certificate of Analysis | May 10, 2024 | K103025 | |
| Certificate of Analysis | May 10, 2024 | K103025 | |
| Certificate of Analysis | May 10, 2024 | K103025 | |
| Certificate of Analysis | May 10, 2024 | K103025 | |
| Certificate of Analysis | Apr 08, 2024 | K103025 | |
| Certificate of Analysis | Apr 08, 2024 | K103025 | |
| Certificate of Analysis | Apr 08, 2024 | K103025 | |
| Certificate of Analysis | Jan 17, 2024 | K103025 | |
| Certificate of Analysis | Jan 17, 2024 | K103025 | |
| Certificate of Analysis | Jan 03, 2024 | K103025 | |
| Certificate of Analysis | Dec 27, 2023 | K103025 | |
| Certificate of Analysis | Dec 27, 2023 | K103025 | |
| Certificate of Analysis | Nov 09, 2023 | K103025 | |
| Certificate of Analysis | Oct 27, 2023 | K103025 | |
| Certificate of Analysis | Oct 27, 2023 | K103025 | |
| Certificate of Analysis | Aug 17, 2023 | K103025 | |
| Certificate of Analysis | Aug 17, 2023 | K103025 | |
| Certificate of Analysis | Aug 17, 2023 | K103025 | |
| Certificate of Analysis | Aug 17, 2023 | K103025 | |
| Certificate of Analysis | Aug 17, 2023 | K103025 | |
| Certificate of Analysis | Mar 17, 2023 | K103025 | |
| Certificate of Analysis | Sep 13, 2022 | K103025 | |
| Certificate of Analysis | Jul 21, 2021 | K103025 |
| Löslichkeit | Solvent:water, Max Conc. mg/mL: 43.69, Max Conc. mM: 75 |
|---|---|
| Spezifische Drehung [α] | 117.5 ° (C=1, H2O) |
| Schmelzpunkt (°C) | 250°C(dec.)(lit.) |
| Molekulargewicht | 582.6 |
| XLogP3 | |
| Hydrogen Bond Donor Count | 13 |
| Hydrogen Bond Acceptor Count | 19 |
| Rotatable Bond Count | 6 |
| Exact Mass | 582.205 Da |
| Monoisotopic Mass | 582.205 Da |
| Topological Polar Surface Area | 366.000 Ų |
| Heavy Atom Count | 38 |
| Formal Charge | 0 |
| Complexity | 720.000 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 15 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| The total count of all stereochemical bonds | 0 |
| Covalently-Bonded Unit Count | 2 |
H360:May damage fertility or the unborn child
H360D:May damage the unborn child
P201:Obtain special instructions before use.
P202:Do not handle until all safety precautions have been read and understood.
P280:Wear protective gloves/protective clothing/eye protection/face protection.
P308+P313:IF exposed or concerned: Get medical advice/attention.
P405:Store locked up.
P501:Dispose of contents/container to an approved waste disposal plant.